HEALTHJun 19 · 02:07 UTCEURACTIVVasiliki Angouridi

Czechia advances as a top clinical trials hub – but global rivals are closing in [Advocacy Lab]

Czechia is advancing as a top clinical trials hub, with sponsor-funded trials estimated to save the Czech healthcare system €85 million in 2025. However, global competitors are narrowing the gap in this sector.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

CzechiaplaceCzech innovative businessorganizationsponsor-funded clinical trialstopichealthcare systemtopicglobal rivalstopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJun 17 · 03:00 UTC
Do we want to lead or lag in life sciences?
HEALTHMay 15 · 13:29 UTC
STAT+: Pharmalittle: We’re reading about U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and more
HEALTHMay 29 · 13:34 UTC
STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
BUSINESSJun 3 · 11:06 UTC
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas